4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000259
EVP, Corp and Development Ops sold 23,900 shares at an average $72.13 ($1,723,987)
- EVP, Corp and Development Ops acquired 23,900 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Birchler Brian · EVP, Corp and Development Ops
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +11,475 | $53.77 | $617,011 | 68,301 | D |
| 2025-10-14 | Sale : show line 2 in the form 10b5-1 | −11,475 | $72.03 | $826,589 | 56,826 | D |
| 2025-10-15 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,425 | $53.77 | $668,092 | 69,251 | D |
| 2025-10-15 | Sale : show line 4 in the form 10b5-1 | −12,425 | $72.23 | $897,398 | 56,826 | D |
| Open-market sales · 23,900 sh · avg $72.13 · $1,723,987 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-14 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −11,475 | 12,425 | D |
| 2025-10-15 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −12,425 | 0 | D |
Loading xslF345X05/edgardoc.xml…